Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1304-1311

  Arifuzzaman, Mohammad ^a,b,g   Rashu, Rasheduzzaman ^a   Leung, Daniel T ^a,b,c   Hosen, M Ismail ^a   Bhuiyan, Taufiqur Rahman ^a   Bhuiyan, M Saruar ^a   Rahman, Mohammad Arif ^a   Khanam, Farhana ^a   Saha, Amit ^a   Charles, Richelle C ^b,c   LaRocque, Regina C ^b,c   Weil, Ana A ^b   Clements, John D ^d   Holmes, Randall K ^e   Calderwood, Stephen B ^b,c   Harris, Jason B ^b,c   Ryan, Edward T ^b,c,f   Qadri, Firdausi ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; CYTOKINE; IMMUNOGLOBULIN G;

ADOLESCENT; ANTIGEN SPECIFICITY; ARTICLE; BANGLADESH; CELL ASSAY; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHILD; CHOLERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; INFANT; INFECTION PREVENTION; INNATE IMMUNITY; INTERMETHOD COMPARISON; LYMPHOCYTE ACTIVATION; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL; VACCINATION; VACCINE PRODUCTION; VIBRIO CHOLERAE;

ADOLESCENT; ADULT; ANTITOXINS; B-LYMPHOCYTES; BANGLADESH; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TH1 CELLS; TH17 CELLS; TH2 CELLS; VACCINATION; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84864544247     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00196-12     Document Type: Article

References (48)

1. Agace W. 2010. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Lett. 128:21-23.
2. Ahmed T, Arifuzzaman M, Lebens M, Qadri F, Lundgren A. 2009. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation. Vaccine 28:422-429.
3. Alam MM, et al. 2011. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin. Vaccine Immunol. 18:844-850.
4. Bhuiyan TR, et al. 2009. Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation. Infect. Immun. 77:1888-1893.
5. Breitfeld D, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545-1552.
6. Briskin M, et al. 1997. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151:97-110. (Pubitemid 27283962)
7. Campbell DJ, Kim CH, Butcher EC. 2001. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2:876-881.
8. Castello-Branco LR, Griffin GE, Poulton TA, Dougan G, Lewis DJ. 1994. Characterization of the circulating T-cell response after oral immunization of human volunteers with cholera toxin B subunit. Vaccine 12:65-72.
9. Clemens JD, et al. 1990. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335:270-273. (Pubitemid 20047723)
10. Crotty S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29:621-663.
11. Datta SK, et al. 2010. Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc. Natl. Acad. Sci. U. S. A. 107:10638-10643.
12. Deen JL, et al. 2008. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl. Trop. Dis. 2:e173. doi:10.1371/journal.pntd.0000173.
13. Elias D, et al. 2001. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin. Exp. Immunol. 123:219-225. (Pubitemid 32174772)
14. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. 2009. Follicular helper T cells: lineage and location. Immunity 30:324-335.
15. Foulds KE, Wu CY, Seder RA. 2006. Th1 memory: implications for vaccine development. Immunol. Rev. 211:58-66. (Pubitemid 43882961)
16. Gaines H, Andersson L, Biberfeld G. 1996. A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry. J. Immunol. Methods 195:63-72. (Pubitemid 26292689)
17. Gorfu G, Rivera-Nieves J, Ley K. 2009. Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr. Mol. Med. 9:836-850.
18. Hanlon P, et al. 1987. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet i:1342-1345.
19. Hardtke S, Ohl L, Forster R. 2005. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood 106:1924-1931. (Pubitemid 41291702)
20. Harris AM, et al. 2009. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 77:3850-3856.
21. Kao JY, et al. 2010. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138:1046-1054.
22. Kim CH, et al. 2001. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193:1373-1381. (Pubitemid 32565966)
23. Koelle K, Rodo X, Pascual M, Yunus M, Mostafa G. 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436:696-700. (Pubitemid 41117271)
24. Kuchta A, et al. 2011. Vibrio cholerae O1 infection induces proinflammatory CD4+T-cell responses in blood and intestinal mucosa of infected humans. Clin. Vaccine Immunol. 18:1371-1377.
25. Lagos R, et al. 1999. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 180:1709-1712. (Pubitemid 29506480)
26. Levine MM, et al. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820. (Pubitemid 11062231)
27. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. 2003. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71:1755-1762. (Pubitemid 36368704)
28. Lundin BS, Johansson C, Svennerholm AM. 2002. Oral immunization with a Salmonella enterica serovar Typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans. Infect. Immun. 70:5622-5627.
29. Moser B, Schaerli P, Loetscher P. 2002. CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol. 23:250-254. (Pubitemid 34499562)
30. Norton EB, Lawson LB, Freytag LC, Clements JD. 2011. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin. Vaccine Immunol. 18:546-551.
31. Nurieva RI, et al. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29:138-149.
32. Patriarca PA, Wright PF, John TJ. 1991. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev. Infect. Dis. 13:926-939.
33. Qadri F, et al. 1994. Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin. Diagn. Lab Immunol. 1:51-54. (Pubitemid 2036283)
34. Rahman KM, et al. 2009. Familial aggregation of Vibrio cholerae-associated infection in Matlab, Bangladesh. J. Health Popul. Nutr. 27:733-738.
35. Rahman M, Sack DA, Mahmood S, Hossain A. 1987. Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures. J. Clin. Microbiol. 25:2204-2206. (Pubitemid 17151534)
36. Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763. (Pubitemid 38680440)
37. Sallusto F, Lanzavecchia A, Araki K, Ahmed R. 2010. From vaccines to memory and back. Immunity 33:451-463.
38. Scriba TJ, et al. 2010. Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur. J. Immunol. 40:279-290.
39. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM. 2011. Oral vaccines for preventing cholera. Cochrane Database Syst. Rev. 2011:CD008603. doi:10.1002/14651858.CD008603.pub2.
40. Stober CB, Lange UG, Roberts MT, Alcami A, Blackwell JM. 2005. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J. Immunol. 175:2517-2524. (Pubitemid 41113863)
41. Sur D, et al. 2011. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl. Trop. Dis. 5:e1289. doi:10.1371/journal.pntd.0001289.
42. Svahn A, et al. 2003. Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J. Immunol. Methods 277:17-25. (Pubitemid 36694370)
43. Teran R, et al. 2011. Immune system development during early childhood in tropical Latin America: evidence for the age-dependent down regulation of the innate immune response. Clin. Immunol. 138:299-310.
44. van Gent R, et al. 2009. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin. Immunol. 133:95-107.
45. Weil AA, et al. 2009. Memory T-cell responses to Vibrio cholerae O1 infection. Infect. Immun. 77:5090-5096.
46. WHO. 2010. Cholera vaccines: WHO position paper. Wkly. Epidemiol. Rec. 85:117-128.
47. WHO. 2009. Cholera: global surveillance summary, 2008. Wkly. Epidemiol. Rec. 84:309-324.
48. Wolf AA, et al. 2008. Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules. Infect. Immun. 76:1476-1484. (Pubitemid 351561991)